متابعة
Jarno Salonen
Jarno Salonen
Department of Physics and Astronomy, University of Turku, Finland
بريد إلكتروني تم التحقق منه على utu.fi
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs
J Salonen, L Laitinen, AM Kaukonen, J Tuura, M Björkqvist, T Heikkilä, ...
Journal of controlled release 108 (2-3), 362-374, 2005
6532005
Mesoporous silicon in drug delivery applications
J Salonen, AM Kaukonen, J Hirvonen, VP Lehto
Journal of pharmaceutical sciences 97 (2), 632-653, 2008
5652008
Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats
LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ...
ACS nano 4 (6), 3023-3032, 2010
3712010
Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices
N Genina, J Holländer, H Jukarainen, E Mäkilä, J Salonen, N Sandler
European Journal of Pharmaceutical Sciences 90, 53-63, 2016
3302016
Mesoporous silica material TUD-1 as a drug delivery system
T Heikkilä, J Salonen, J Tuura, MS Hamdy, G Mul, N Kumar, T Salmi, ...
International journal of pharmaceutics 331 (1), 133-138, 2007
2882007
Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering
M Kaasalainen, V Aseyev, E von Haartman, DŞ Karaman, E Mäkilä, ...
Nanoscale research letters 12, 1-10, 2017
2332017
Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery
T Heikkilä, J Salonen, J Tuura, N Kumar, T Salmi, DY Murzin, MS Hamdy, ...
Drug delivery 14 (6), 337-347, 2007
2212007
The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
MA Shahbazi, M Hamidi, EM Mäkilä, H Zhang, PV Almeida, ...
Biomaterials 34 (31), 7776-7789, 2013
2172013
Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods
T Limnell, HA Santos, E Mäkilä, T Heikkilä, J Salonen, DY Murzin, ...
Journal of pharmaceutical sciences 100 (8), 3294-3306, 2011
2162011
Multistaged nanovaccines based on porous silicon@ acetalated dextran@ cancer cell membrane for cancer immunotherapy
F Fontana, MA Shahbazi, D Liu, H Zhang, E Mäkilä, J Salonen, ...
Advanced Materials 29 (7), 1603239, 2017
2102017
Fabrication and chemical surface modification of mesoporous silicon for biomedical applications
J Salonen, VP Lehto
Chemical Engineering Journal 137 (1), 162-172, 2008
2072008
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size
HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ...
Acta biomaterialia 6 (7), 2721-2731, 2010
2032010
Semimetallic TiO2 Nanotubes
R Hahn, F Schmidt‐Stein, J Salonen, S Thiemann, YY Song, J Kunze, ...
Angewandte Chemie International Edition 48 (39), 7236-7239, 2009
1862009
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
LM Bimbo, E Mäkilä, T Laaksonen, VP Lehto, J Salonen, J Hirvonen, ...
Biomaterials 32 (10), 2625-2633, 2011
1842011
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles
T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ...
Chemical research in toxicology 20 (12), 1913-1918, 2007
1832007
Stabilization of porous silicon surface by thermal decomposition of acetylene
J Salonen, M Björkqvist, E Laine, L Niinistö
Applied Surface Science 225 (1-4), 389-394, 2004
1802004
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution
M Sarparanta, LM Bimbo, J Rytkonen, E Makila, TJ Laaksonen, ...
Molecular pharmaceutics 9 (3), 654-663, 2012
1782012
Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
D Liu, LM Bimbo, E Mäkilä, F Villanova, M Kaasalainen, ...
Journal of Controlled Release 170 (2), 268-278, 2013
1772013
Multifunctional porous silicon nanoparticles for cancer theranostics
CF Wang, MP Sarparanta, EM Mäkilä, MLK Hyvönen, PM Laakkonen, ...
Biomaterials 48, 108-118, 2015
1752015
The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
F Araújo, N Shrestha, MA Shahbazi, P Fonte, EM Mäkilä, JJ Salonen, ...
Biomaterials 35 (33), 9199-9207, 2014
1722014
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20